Before the Bell Scans: Pharmacyclics, United Therapeutics, Impax Laboratories, and Star Scientific Editor Note: For more information about this release, please scroll to bottom.
LONDON, June 24, 2013 /PRNewswire/ --
On Friday, June 21, 2013, shares in drug manufacturers ended on a mixed note, tracking the broader market which also finished mixed after witnessing losses in two successive trading sessions. The major movers included Pharmacyclics Inc. (NASDAQ: PCYC), United Therapeutics Corporation (NASDAQ: UTHR), Impax Laboratories Inc. (NASDAQ: IPXL), and Star Scientific Inc. (NASDAQ: STSI). All these companies are tracked by AAAResearchReports.com. Free technical research on PCYC, UTHR, IPXL, and STSI can be downloaded upon sign up at
Shares in Pharmacyclics Inc. ended slightly lower on Friday, extending their losses from previous trading sessions. The company's shares oscillated between $78.23 and $81.96 before closing the day at $81.00, down 0.36%. A total of 1.05 million shares were traded which is above the daily average volume of 739,954. Pharmacyclics' shares have now declined by over 8.20% in the last three sessions. Sign up today to read free research report on PCYC at:
United Therapeutics Corporation's stock posted modest gains on Friday, reversing some of its losses from previous market sessions. The company's shares ended the day at $63.34, up 0.19%, after trading between $62.78 and $64.55. A total of 818,292 shares were traded which is above the daily average volume of 567,754. United Therapeutics' shares have slipped by more than 3.50% in the last three trading sessions. However, despite the recent losses, the stock is still up 3.92% in the last three months. Register to download free technical analysis on UTHR at:
Shares in Impax Laboratories Inc. moved higher on Friday, paring some of its losses from its previous two trading sessions. The company's shares traded between $17.69 and $18.22 before finishing the day 0.72% higher at $18.09. A total of 1.54 million shares were traded which is above the daily average volume of 1.15 million. Impax's shares have now fallen more than 4% in the last three sessions. In the last three months, the stock has gained over 15.80%, thus outperforming the S&P 500. Additionally, shares of the company are currently trading slightly above their 50-day moving average. A free report on IPXL can be accessed by registering at:
Star Scientific Inc.'s stock rose sharply on Friday, closing 1.53% higher at $1.33 after trading between $1.24 and $1.33. A total of 1.73 million shares were traded which is above the daily average volume of 1.07 million. However, despite the sharp rise on Friday, the company's shares have fallen by 8.28% in the last three trading sessions. Moreover, the stock is also trading above its 50-day and 200-day moving average. Register with AAA Research Reports and download the research on STSI for free at:
- This is not company news. We are an independent source and our views do not reflect the companies mentioned.
- Information in this release is fact checked and produced on a best efforts basis and reviewed by a CFA. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
- This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
- If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com.
- For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com.
- Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration.
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider has, through Chartered Financial Analysts, only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
SOURCE AAA Research Reports